AHR and breast adenocarcinoma: Further studies showed that G protein-coupled receptor 30 (GPR30) agonist G-1 increased AhR signaling by inhibition of tubulin assembly and cell cycle arrest in human breast adenocarcinoma (MCF-7) cells (Tarnow et al. 2016).